Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
FDA prescribing information recommends healthcare providers consider alternative therapies for patients with prior pancreatitis, as semaglutide has not been adequately studied in this population
A study found that one year after stopping semaglutide (generic for Ozempic) patients regained 2/3rds of their prior weight loss over the next 52 weeks
Data are presented as mean s.e.m
But in April, CMS indefinitely postponed the test and extended the bridge program by a year
References PubMed
Because the program is directed by a bariatric surgeon, patients receive consistent guidance whether they are focusing solely on medication or exploring surgical options down the road
